Steward Partners Investment Advisory’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4K | Hold |
4,000
| – | – | ﹤0.01% | 3118 |
|
|
2025
Q1 | $14K | Hold |
4,000
| – | – | ﹤0.01% | 2951 |
|
|
2024
Q4 | $13.1K | Hold |
4,000
| – | – | ﹤0.01% | 2986 |
|
|
2024
Q3 | $15.4K | Hold |
4,000
| – | – | ﹤0.01% | 2764 |
|
|
2024
Q2 | $12.4K | Hold |
4,000
| – | – | ﹤0.01% | 2734 |
|
|
2024
Q1 | $10.3K | Hold |
4,000
| – | – | ﹤0.01% | 2800 |
|
|
2023
Q4 | $10K | Hold |
4,000
| – | – | ﹤0.01% | 2717 |
|
|
2023
Q3 | $8.12K | Hold |
4,000
| – | – | ﹤0.01% | 2671 |
|
|
2023
Q2 | $9.2K | Hold |
4,000
| – | – | ﹤0.01% | 2593 |
|
|
2023
Q1 | $12.1K | Hold |
4,000
| – | – | ﹤0.01% | 2469 |
|
|
2022
Q4 | $9.32K | Sell |
4,000
-1,000
| -20% | -$2.33K | ﹤0.01% | 2562 |
|
|
2022
Q3 | $10K | Hold |
5,000
| – | – | ﹤0.01% | 2516 |
|
|
2022
Q2 | $14K | Sell |
5,000
-2,000
| -29% | -$5.6K | ﹤0.01% | 2367 |
|
|
2022
Q1 | $21K | Hold |
7,000
| – | – | ﹤0.01% | 2328 |
|
|
2021
Q4 | $27K | Hold |
7,000
| – | – | ﹤0.01% | 2186 |
|
|
2021
Q3 | $30K | Hold |
7,000
| – | – | ﹤0.01% | 2122 |
|
|
2021
Q2 | $21K | Hold |
7,000
| – | – | ﹤0.01% | 5013 |
|
|
2021
Q1 | $23.3K | Hold |
7,000
| – | – | ﹤0.01% | 2406 |
|
|
2020
Q4 | $25K | Buy |
+7,000
| New | +$25K | ﹤0.01% | 1972 |
|